PMC:7317273 / 20999-21164
Annnotations
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T107 | 135-153 | Disease | denotes | pulmonary fibrosis | http://purl.obolibrary.org/obo/MONDO_0002771 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T246 | 161-163 | http://purl.obolibrary.org/obo/CLO_0001313 | denotes | 36 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T84 | 117-126 | Chemical | denotes | bleomycin | http://purl.obolibrary.org/obo/CHEBI_22907 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 327 | 117-126 | Chemical | denotes | bleomycin | MESH:D001761 |
| 335 | 10-17 | Disease | denotes | hypoxia | MESH:D000860 |
| 336 | 135-153 | Disease | denotes | pulmonary fibrosis | MESH:D011658 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T326 | 0-165 | Sentence | denotes | Likewise, hypoxia preconditioning can also improve the proliferation and therapeutic efficacy of MSCs, as evident in bleomycin-induced pulmonary fibrosis model [36]. |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T25 | 10-17 | Phenotype | denotes | hypoxia | http://purl.obolibrary.org/obo/HP_0012418 |
| T26 | 135-153 | Phenotype | denotes | pulmonary fibrosis | http://purl.obolibrary.org/obo/HP_0002206 |
2_test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 32592163-25986930-140679197 | 161-163 | 25986930 | denotes | 36 |
LitCovid-PMC-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T359 | 55-68 | GO:0008283 | denotes | proliferation |
| T360 | 97-101 | DG_47 | denotes | MSCs |
| T361 | 117-126 | CHEBI:22907;CHEBI:22907 | denotes | bleomycin |
| T362 | 135-144 | UBERON:0002048 | denotes | pulmonary |